Field
The present disclosure generally relates to medical devices, and particularly to configuring medical devices to reduce error.
Description of the Related Art
Medication errors, that is, errors that occur in the ordering, dispensing, and administration of medications, regardless of whether those errors cause injury or not, are a significant consideration in the delivery of healthcare in the institutional setting. Additionally, adverse drug events (ADE), which are defined as injuries involving a drug that require medical intervention and are a subset of medication errors, represent some of the most serious medication errors are responsible for a number of patient injuries and death.
Healthcare facilities continually search for ways to reduce the occurrence and severity of medication errors. Various systems and methods are commonly used to reduce the frequency of occurrence and severity of preventable adverse drug events (PADE) and other medication errors. In the administration of medication, focus is typically directed to the following five “rights” or factors: the right patient, the right drug, the right route, the right amount, and the right time. Systems and methods seeking to reduce ADEs and PADEs should take these five rights into consideration.
Delivery, verification, and control of medication in an institutional setting have traditionally been areas where errors can occur. In a typical healthcare facility, a physician enters an order for a medication for a particular patient. This order may be handled either as a simple prescription slip, or it may be entered into an automated system, such as a physician order entry (POE) system. The prescription slip or the electronic prescription from the POE system is routed to the pharmacy, where the order is filled. Typically, pharmacies check the physician order against possible allergies of the patient and for possible drug interactions in the case where two or more drugs are prescribed, and also check for contraindications. Depending on the healthcare facility, the medication may be identified and gathered within the pharmacy and placed into a transport carrier for transport to a nurse station. Once at the nurse station, the prescriptions are again checked against the medications that have been identified for delivery to ensure that no errors have occurred. Each of these steps or workflows is typically captured as event data in a hospital information system. The event data is not, however, used to adjust future workflows involving medical items. For example, a medical item from a dispensing cabinet may have an associated warning related to how commonly the medical item is wasted. This information is not, however, used to adjust future workflows from reducing waste of the medical item.
According to one embodiment of the present disclosure, a method for facilitating safe use of a medical item is provided. The method includes receiving a first identifier for a medical entity located in an institution. The medical entity includes at least one of a patient, medical device, medical location, or medical item. The method also includes receiving a second identifier for a first course of action associated with the medical entity. The method further includes generating, based on a history of the medical entity and the first course of action associated with the medical entity, a second course of action for the medical entity, and providing a notification to a device indicating the second course of action.
According to another embodiment of the present disclosure, a monitoring system for facilitating safe use of a medical item is provided. The system includes a memory that includes a history of a medical entity located in an institution. The medical entity includes at least one of a patient, medical device, medical location, or medical item. The system also includes a processor. The processor is configured to receive a first identifier for the medical entity and a second identifier for a first course of action associated with the medical entity, and generate, based on a history of the medical entity and the first course of action associated with the medical entity, a second course of action for the medical entity. The processor is also configured to provide a notification to a device indicating the second course of action.
According to a further embodiment of the present disclosure, a machine-readable storage medium that includes machine-readable instructions for causing a processor to execute a method for facilitating safe use of a medical item is provided. The method includes receiving a first identifier for a medical entity located in an institution. The medical entity includes at least one of a patient, medical device, medical location, or medical item. The method also includes receiving a second identifier for a first course of action associated with the medical entity. The method further includes generating, based on a history of the medical entity and the first course of action associated with the medical entity, a second course of action for the medical entity, and providing a notification to a device indicating the second course of action.
According to yet a further embodiment of the present disclosure, a method for instructing a caregiver is provided. The method includes receiving a first identity of a caregiver at an institution and a proposed course of action for a medical entity, and generating, based on a history of the caregiver within the institution, a modified course of action. The method also includes providing a notification of the modified course of action to the caregiver.
It is understood that other configurations of the subject technology will become readily apparent to those skilled in the art from the following detailed description, wherein various configurations of the subject technology are shown and described by way of illustration. As will be realized, the subject technology is capable of other and different configurations and its several details are capable of modification in various other respects, all without departing from the scope of the subject technology. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not as restrictive.
The accompanying drawings, which are included to provide further understanding and are incorporated in and constitute a part of this specification, illustrate disclosed embodiments and together with the description serve to explain the principles of the disclosed embodiments. In the drawings:
In the following detailed description, numerous specific details are set forth to provide a full understanding of the present disclosure. It will be apparent, however, to one ordinarily skilled in the art that the embodiments of the present disclosure may be practiced without some of these specific details. In other instances, well-known structures and techniques have not been shown in detail so as not to obscure the disclosure.
Each of the steps of a workflow related to a medical entity, such as a patient, medical device, medical location, or medical item, can be captured as event data in a hospital information system. The event data can be, for example, historical data related to the medical entity. The disclosed system leverages the event data for the medical entity to determine, for example, whether to suggest an alternative workflow for the medical entity. For instance, event information for a medication from a dispensing cabinet may be evaluated by the disclosed system to determine a percentage of times the medication is wasted. The disclosed system may then send a notification to a caregiver attempting to dispense the medication regarding the potential wastage, and may further restrict the caregiver from dispensing the medication until additional verification steps are taken. Similar notifications and workflow suggestions can be suggested for improving a health level of a patient, expediting dispensing of a medical item, indicating an incidence rate of illness in a medical location, or a recommending an increase of an order being placed for medical items based on a recent change in demand for the medical item. The notifications and other workflow suggestions can be specific to the caregiver specific when, for example, an abnormal utilization pattern for a medical item is specific to the caregiver.
Several examples will now be presented regarding how the disclosed system can assist a caregiver in facilitating a safe interaction with a medical entity. As one example, a notification can be sent if a certain medication is continuously used to address a certain pathology when it is shown that the patient length of stay is not improved over time using that medication. As another example, a specific nurse can be alerted to check on order information if the nurse is historically hitting safe or therapeutic limits on doses too often. As yet another example, a specific caregiver can be informed that the caregiver's level of drug waste is high on average. As a further example, a pharmacist can be informed that a certain medication may be required statim (e.g., “stat” or urgently) because the medication has historically taken a long time to be delivered to a patient.
Referring now to the drawings,
The facility communication system 30 is not meant to be taken in a limited sense. Such a facility communication system 30 may encompass an entire healthcare facility or may be located only in a small area of the healthcare facility. It may also include a communication system in a healthcare facility other than a hospital and may have application to an alternate care facility, such as a patient's home. Additionally, the word caregiver is intended to be used in its broadest sense and is meant to include nurses, physicians, health care specialists, and others who provide care to patients.
The monitoring system 40 in accordance with an aspect of the present disclosure may be, for example, a server or other computer having sufficient memory 42 and processing capability to connect with the communication system 30 and determine a change in workflow for a healthcare process. The monitoring system 40 includes operational software or other instructions for carrying out various aspects of the present disclosure, as will be discussed more fully below, enabling communications with other hardware or networks, and data input and output and report generation and printing, among other functions. While the monitoring system 40 is shown as a separate piece of equipment, it will be understood that the monitoring system 40 and the associated memory 42 may also be incorporated into another element, such as the medical device 80.
The communication system 30 may comprise, for example, a wired or wireless Ethernet (IEEE 522.3) utilizing transmitters and receivers positioned throughout the healthcare facility and/or attached to various computers, clinical devices and other equipment used in the facility. In such a wireless system, the signals transmitted and received by the system could be radio frequency (RF), infrared (IR), or other means capable of carrying information in a wireless manner between devices having appropriate transmitters or receivers may be used. It will be immediately understood by those skilled in the art that such a system may be identical to the system set forth in
In a typical healthcare facility, patient rooms, wards, or areas are typically situated in groups located near a nurse station 44, where the caregivers assigned to care for the patients in the particular area carry out the administrative functions of their duties. Typically, these functions include updating and monitoring the patients' charts, preparation of and administering medication orders, and monitoring and recording any other information deemed necessary by the facility for tracking. There is also usually a room located adjacent the nurse station that is dedicated to storage and/or the preparation of medications to be delivered to patients. This room may contain inventories of commonly used oral, IM, or IV medications. The room may also be used to formulate the contents of infusion bags in accordance with prescribed treatment regimens.
The nurse station 44 will typically include a terminal or computer system 46 connected either directly or through an interface 48 to the communication system 30, allowing users at the nurse station to enter and retrieve patient data or information from other systems, such as the healthcare facility information system 34, the pharmacy information system 36, the physician order entry system 38, or other systems used in the facility. It should be understood that not all users will be provided with access rights to each system. For example, physicians may be able to access the physician order entry system 38 from the nurse station system 44 to enter, edit, or track medication orders, but a caregiver may only be able to view such orders. Moreover, while the present disclosure is described with reference to the computer system 46 being located at a nurse station 44, the computer system 46 may also be a satellite system that is located anywhere in the care-giving facility where it is convenient or efficient to do so. Such a satellite computer system may be operably connected to the communication system 30 using either a wired or wireless network connection. A printer 50 may also be connected to the nurse station computer system 46 for printing reports, bar codes, labels, or other materials, and a bar code reader 52 may be provided for reading bar codes on medication labels, reports, or other items having bar coded labels provided for identification.
In a different embodiment where radio frequency identification (RFID) tags are used with medications, patients, equipment, or in other ways, the nurse station 44 may also include an interrogator or RFID reader (not shown) for use with the RFID tags.
In accordance with aspects of the present disclosure, a medical entity database 60 stores information related to medical entities, such as patients, medical devices, medical locations, and medical items. Various types of information may be stored in the memory of the medical entity database 60, including medical item history and course of action information (e.g., orders, history of use, caregivers associated with the item, etc.). Databases can also be stored in the database 60 that contain information about drug interactions and possible contraindications and/or side-effects of medications, and established guidelines for the administration of various medications. For example, the guidelines may include institutionally-established guidelines or limits on drug administration parameters, such as dosage, frequency of administration, and other delivery related information such as, for example, appropriate flow rates and infusion durations for programming infusion pumps. Additionally, the guidelines may encompass guidelines for providing drug administration appropriate to a particular patient or to treatment areas having different sets of delivery parameters for similar medications, such as medication administration directed to geriatric, pediatric, and oncology patients. Guidelines may also be included that are directed to particular therapy regimens, such as chemotherapy regimens or regimens for treating chronic infection or pain. The term database as used herein will be understood by those skilled in the art to be used as is commonly understood. That is, the term database refers to a collection of values or information organized, formatted, and stored in such a manner as to be capable of being retrieved and analyzed using an appropriate program contained in software or other form.
The medications guidelines database 60 may be stored on a device, such as a server. The healthcare facility may also or alternatively have the medical entity database 60 centrally located in the memory 42 of the monitoring system 40. The medical entity database 60 includes medication information, medical item history, and course of action information, and/or databases or libraries, including institutionally generated guidelines for the delivery of medication to a patient, as well as drug interaction information or information concerning possible drug side-effects. The medications guidelines database 60 may also have a storage capability and technology for interfacing with a computer system or network so that information may be communicated between the medications guidelines database 60 and other devices, such as computers, medication administration devices, clinical devices such as vital signs monitoring devices and the like. A general concept embodied in the medications guidelines database 60 is to provide safe medication guidelines for dispensing, administering, or otherwise providing medication a patient using, for example, a medical device 80 such as an infusion pump.
In accordance with aspects of the present disclosure, the monitoring system 40 is configured to obtain medical entity information from the medical entity database 60. The medical entity database 60 is configured to obtain device information from the medical device 80, previous medical item history and course of action information (e.g., orders, history of use, caregivers associated with the item, etc.) from physician order entry system 38, the pharmacy information system 36, and the healthcare facility information system 34. Information may be retrieved information from the medical device 80 prior to actual medication administration. Monitoring system 40 can determine, based on a history of a medical entity and a current course of action for the medical entity, whether an alternative course of action should be taken for the medical entity. If the determination indicates an alternative course of action should be taken, then the monitoring system 40 is configured to transmit a notification to a relevant caregiver or device indicating the alternative course of action. The monitoring system 40 may also restrict or otherwise inhibit the current course of action from being taken (e.g., by locking a device).
For example, physician order system 38 may indicate that a certain medication is to be provided to a patient, and the pharmacy information system 36 may indicate how often the medication has been dispensed to the patient in the past. Based on this information, the monitoring system 40 may determine that dispensing the medication to the patient is harmful according to certain medical guidelines (e.g., from medical entity database 60). The monitoring system may then prevent a medical device 80 from dispensing the medication by locking the medical device 80 and possibly requiring a manual override of the lock in order to dispense the medication to the patient.
As another example, the pharmacy information system 36 may indicate that an order for 30 doses of a medication is to be placed, and the healthcare facility information system 34 may indicate that an incidence of an illness (e.g., with reference to patient laboratory data) that is treated by the medication has increased sharply in the past 24 hours. Based on the order and incidence information, the monitoring can send a notification to the pharmacy information system 36 to increase the number of doses being ordered, and may provide a suggested amount based on the incidence information.
As yet a further example, the healthcare facility information system 34 may include a caregiver's history regarding medication and medical device usage, and the medical entity database 60 may indicate an appropriate amount of a medication the caregiver has given in the past. The monitoring system 40 may determine that the amount of the medication the caregiver has given in the past has been inadequate, and send a notification to the medical device 80 or another device of the caregiver indicating that the medication amount provided by the caregiver should be increased.
While specific examples of a monitoring system 40 are set forth herein, it will be understood that the monitoring system 40 is meant to include any device that carries out the basic concept of the disclosure. That is, a device that receives an identification of a medical entity, such as a patient, medical device, medical location, or medical item, and an identification of a course of action associated with the medical entity, and has a processor that generates, based on a history of the medical entity and the course of action associated with the medical entity, a second (e.g., alternative) course of action for the medical entity, and provides a notification to a device (e.g., device of a caregiver, medical device 80, physician order entry system 38, pharmacy information system 36, healthcare facility information system 34) indicating the second course of action.
One particular mode of operation of the present disclosure will now be described. A patient entering a healthcare facility is provided with a wrist band, necklace, ankle band, or other band, chain, or device designed to remain affixed to or embedded in the patient during the patient's entire stay in the healthcare facility (the “patient ID”). The patient ID is designed to remain affixed in a manner so that the patient can be identified even if unconscious or otherwise unresponsive. The patient ID is used to identify specific patient data, such as the patient's name and other information that the facility has determined is important, such as age, allergies, or other vital information. The patient identifying device may comprise a bar code, written information, or an electronic information storage device, such as an RF transponder (e.g., RFID tag), that contains the information, or other device affixed to the patient. In the case where the patient-specification information may also include the patient's medication administration record (MAR). This would allow for consistent documentation and also checks against drug interaction in the medical entity database 60.
Such RFID tags, barcodes, and other technologies useful in identification, may be applied to others and to other things in providing healthcare to patients. For example, physicians, nurses, and other caregivers, as well as others who have access to patients and facilities, may also have an RFID tag that can be read anywhere in the healthcare facility. The medical fluid containers may contain RFID tags having information about the contents of the container as well as the patient for whom they have been prepared, the pharmacist who prepared them, and the physician who prescribed them. The infusion pumps and other healthcare instruments and devices may have RFID tags useful for inventory control. Even though the instruments may be connected to the healthcare facility communication system 30, RFID tags can be useful for manual inventory purposes as well as for other purposes. Their low cost makes them attractive as a backup support system.
After the patient is admitted and situated in a bed within the facility, the patient is typically evaluated by a physician and a course of treatment is prescribed. The physician prescribes a course of treatment by preparing an order that may request a series of laboratory tests or the administration of a particular medication to the patient. In some cases, the physician prepares the order by filling in a form or writing the order on a slip of paper to be entered into the healthcare facility system for providing care. In other cases, the physician may enter the medication order directly into a physician order entry system 38 or may instruct a nurse or other care-giving professional to do so. In yet another case, the physician may use the Internet to forward and enter a prescription for the patient into the pharmacy system. Depending on the arrangement at the healthcare facility, the physician's order or prescription may directly reach a website for the pharmacy information system 36 or may go to a website for the healthcare facility where it may then be routed to the pharmacy information system 36. In certain aspects, the monitoring system 40 may review the prescribed course of treatment for the patient and the history of prescriptions by the physician or other physicians, and propose an alternative treatment for the patient to the physician for review.
Pharmacy information systems 36 may enable a safer physician medication order process. The pharmacy information system 36 may provide the physician with a list of available drugs from which the physician may select. The pharmacy information system 36 may contain a drug library having the list of available drugs but may also contain and present to the physician the drug names associated with recommended dosages and dose limits that have been established or adopted by the healthcare facility. In such a case where the physician need only select items from the computer screen rather than having to manually type in drug names and drug administration numbers (such as infusion rates, times, etc.) associated with administration of the medication, a more accurate medication process should result.
If the order is for administration of a particular medication regimen, the order will be transmitted to the facility's pharmacy information system 36. The pharmacy reviews the order. In certain aspects, the monitoring system 40 may, for example, review the particular medication regimen for the patient and the history of medication regimens for the patient or similar patients, and then propose an medication regiment for the patient to the pharmacist (or physician) for review.
The pharmacy prepares the medication according to the requirements of the physician. Typically, the pharmacy packages the medication in a container, and a copy of the order, or at a minimum the patient's name, the drug name, and the appropriate treatment parameters are represented on a label or other device that is affixed to the drug container. This information may be represented by a bar code, or it may be stored in a smart label, such as a label having an embedded computer, or in a passive device such as an RFID tag discussed above.
Once the order has been prepared, the order is sent to the nurse station 44 for matching with the appropriate patient. Alternatively, if the medication is for a commonly or routinely prescribed medication, the medication may be included in an inventory of medications that is stored in a secure cabinet adjacent the nurse station 44. In such a case, the nurse station 44 will receive a list of orders from the pharmacy information system 36 that may be drawn from the inventory adjacent the nurse station 44. The caregiver will enter a unique identifier at the cabinet to gain access in accordance with standard practice. The caregiver or other professional assigned the task of gathering medications will then match the orders received from the pharmacy information system 60 to the medications stored in the inventory and pull those medications that are to be delivered to specific patients. These procedures are carried out whether the medication to be delivered is an oral medication or a medication that is to be delivered intramuscularly or through an infusion. In certain aspects, the monitoring system 40 may review the medication orders to determine, for example, whether the caregiver has a particularly high level of waste for the medication order being dispensed. If such a determination is made, the monitoring system 40 may send a notification to the nurse station 44 for the caregiver to view. The notification can state, for example, the caregiver's recorded history of waste and either remind the caregiver to be careful in dispensing the medication order, or propose an alternative workflow to dispensing the medication order.
In certain circumstances, a pharmacy dispenses a vial of a medication (a “multidose vial”) that includes more than the specific dose of the medication required for a patient. one advisory that we should give the nurse is exactly how to prepare the medication. A nurse or other caregiver may then be tasked calculating an appropriate dose of the medication for the patient based on the total amount of medication included in the vial. For example, a physician may order that a 65 kg patient receive a 40 unit/kg bolus dose, and the administration of the medication should be at a rate not to exceed 400 units/minute. The vial of the medication contains 1000 units/mL. The nurse must manually calculate the total dose of the vial, namely, that the vial contains 2600 units of the medication. The nurse must then determine that this is 2.6 mL of the 1000 units/mL, and then calculate the dose injection for a minimum time of 6.5 minutes. The disclosed monitoring system 40 may advantageously provide this information to the nurse so that the nurse, such as a notification to remove 2.6 mL of the 1000 units/mL medication and administer at 0.4 Ml/min, and further provide the syringe label complete with patient, drug, dose and bar code to the nurse.
When the prescribed time for delivery of the medication or medications arrives, the medications are carried to the patient's area and administered to the patient by the caregiver. In the case of drugs to be delivered via infusion, the caregiver hangs the infusion bag and prepares the infusion line, attaches the bag to an infusion pump 80, and sets up the infusion pump to deliver the medication by programming the pump with values for various parameters that are used by the pump to control delivery of the medication to the patient. When the medication delivery parameters are entered into the pump, the pump communicates the entered parameters to the medical entity database 60. In certain aspects, the monitoring system 40 may, for example, review the medication delivery parameters and a history of previous medication delivery parameters entered into the infusion pump 80 to deliver the medication or similar medications, and determine that alternative medication delivery parameters should be used. If such a determination is made, the monitoring system 40 may send a notification to the infusion pump 80 for the caregiver to view. The notification can propose, for example, alternative medication delivery parameters and a reason for proposing the alternative medication delivery parameters. If the alternative medication delivery parameters for the infusion pump 80 are accepted, or alternatively manually overridden, the monitoring system 40 can send a signal to the infusion pump 80 to begin infusion of the medication.
The monitoring system 40 includes a processor 212, the communications module 210, and a memory 42 that includes a monitoring application 208. The monitoring application 208 includes instructions for the processor 212 to obtain, from the processor 136 of the server 130, information from the medical entity database 62 over the network 30 using respective communications modules 210 and 138 of the monitoring system 40 and the server 130. The information received from the medical entity database 62 includes identification information for a medical entity, courses of action associated with the medical entity, and a history of the medical entity. The medical entity can be, for example, a patient, medical device 80, medical location (e.g., hospital or area within a hospital, such as an Intensive Care Unit), or medical item such as a medication or medical. For example, identification information for a medical entity can be a name or unique identifier for a patient. A course of action associated with a medical entity can be providing a prescribed amount of medication to a patient. A history of a medical entity can be a listing of medications administered using a medical device 80.
The processor 212 of the monitoring system 40 is configured to execute instructions, such as instructions physically coded into the processor 212, instructions received from software in memory 42, or a combination of both. For example, the processor 212 of the monitoring system 40 executes instructions from the monitoring application 208 to receive a first identifier for a medical entity located in an institution and a second identifier for a first course of action associated with the medical entity. The first and second identifiers can be received from the medical entity database 62 over the network 30. The processor 212 of the monitoring system is also configured to generate, based on a history of the medical entity and the first course of action associated with the medical entity, a second course of action for the medical entity, and provide a notification to the device 160 indicating the second course of action. The second course of action can be, for example, an alternative to the first course of action selected in order to promote a safe or efficient interaction with the medical entity. The device 160 can be, for example, a caregiver's mobile device, a medical device 80 at or near a patient's bedside, a display at a nurse station 44, or a display of the healthcare facility information system 34, pharmacy information system 36, physician order entry system 38, or monitoring system 40. The notification can include a message indicating a purpose for indicating the second course of action. For example, a notification can be displayed using display device 214 on a caregiver's mobile device 160 indicating a prescribed amount of medication for the patient is too high based on the patient's physiological history relative to administration of the medication, and further indicate an alternative amount of medication that is appropriate to the patient based on the patient's physiological history relative to administration of the medication. The caregiver may then be asked to confirm or override the alternative amount using an input device 216 of the mobile device 160.
The first identifier, the second identifier, or the history of the medical entity can be received from an external data system (e.g., server 130) in a native message format of the external data system, and the processor 212 of the monitoring system 40 can be configured to convert the first identifier, the second identifier, or the history of the medical entity into an internal messaging format configured for use with the monitoring system 40. The processor 212 can be configured to perform the conversion according to the system and method of converting messages being sent between data systems using different communication protocols and message structures described in U.S. patent application Ser. No. 13/421,776, entitled “Scalable Communication System,” and filed on Mar. 15, 2012, the disclosure of which is hereby incorporated by reference in its entirety for all purposes. The memory 42 of the monitoring system 40 can include, for example, an interface module for communicating with the server 130. The interface module can include information on the communication protocol and data structure used by the server 130 and is configured to both receive messages from and transmit messages to the server 130.
In certain aspects where the medical entity is or otherwise includes a medical item, the history of the medical entity can include a number of times the medical item has been dispensed. For example, the history of the medical entity can indicate that the psychoactive drug alprazolam has been dispensed by a specific caregiver over ten times in the past twenty four hours. The first course of action associated with the medical item alprazolam may indicate an instruction to dispense alprazolam for a specific patient, and the second course of action can indicate an instruction to restrict dispensing of alprazolam (e.g., by locking the device 160 for dispensing alprazolam), for example, due to the specific caregiver's abnormally high rate of dispensing of alprazolam. A notification can be sent to the device 160 for dispensing alprazolam or the caregiver's mobile device 160 indicating that dispensing of alprazolam has been restricted based on the caregiver's abnormally high rate of dispensing of alprazolam. Alternatively, the alprazolam may be removed from the listing of available medications to the caregiver (e.g., “unprofiling” the medication) until a pharmacist or other authorized caregiver takes appropriate action, such as contacting the physician or repeating a lab test.
In certain other aspects where the medical entity is or otherwise includes a medical item, the processor 212 of the monitoring system 40 may be configured to receive a third identifier for a caregiver (e.g., from the medical entity database 62 over the network 30) in the institution. The history of the medical item can include a level of waste of the medical item by the caregiver. For example, the history of the medical item can indicate that it is an antihypertensive that is wasted (e.g., dispensed but never used) by the caregiver on average 22% of the times it is dispensed by the caregiver. The waste may occur due to, for example, resolution of the condition for which the medication was prescribed, patient-perceived ineffectiveness, prescription changes by the physician, and patient-perceived adverse effects. The abnormally high rate of wastage by the caregiver may be due to the caregiver being prone to not checking a patient's record before dispensing a medication. The first course of action associated with the antihypertensive medication may indicate an instruction to the caregiver to dispense a ten count of the antihypertensive medication, and the second course of action can indicate an instruction to decrease the dispensing count of the antihypertensive medication to two, or restrict dispensing altogether, for example, based on the caregivers history of wasting the antihypertensive medication. A notification can be sent to the device 160 for dispensing the antihypertensive medication or the caregiver's mobile device 160 indicating that dispensing of the antihypertensive medication has been reduced or restricted due to the caregiver's history of wasting the antihypertensive medication.
In certain further aspects where the medical entity is or otherwise includes a medical item, the history of the medical entity can include an average amount of time between dispensing of the medical item and the medical item being administered to a patient. For example, the average amount of time for dispensing a solution of adrenaline in an institution is 45 minutes, and a first course of action associated with the solution of adrenaline is to dispense the solution of adrenaline according to normal procedures. The second course of action associated with the dispensing solution can be to dispense the solution of adrenaline statim (e.g., according to expedited procedures) because adrenaline is commonly needed urgently to administer to a patient and an average wait time of 45 minutes for the solution is not acceptable. A notification can be sent to the pharmacy information system 36, nurse station 44, or other device 160 indicating the expedited need for the adrenaline solution.
In certain aspects where the medical entity is or otherwise includes a medical location, such as a ward in a hospital, the hospital itself, or a campus of multiple hospitals, the history of the medical location can include, for example, a rate of improvement of patients associated with the medical location. For example, the history of the medical location such as a pediatric intensive care unit (PICU) may indicate a sharp decline in immunity levels of patients in the PICU. The first course of action associated with the medical location may indicate an instruction to order a small amount of a macrolide antibiotic, azithromycin, to treat immunity deficiency in the PICU, and the second course of action can indicate an instruction to recommend an increase in the amount of azithromycin being ordered for the PICU, for example, due to the sharp decline in patient immunity levels. A notification can be sent to the pharmacy information system 36, nurse station 44, or other device 160 indicating the recommendation for the increased need for azithromycin.
In certain other aspects where the medical entity is or otherwise includes a medical location, the history of the medical entity can include an incidence rate of illness associated with the medical location. For example, the history of a specific hospital may indicate that the incidence of the influenza virus has dramatically increased over the past seven days from an average of three new influenza cases per day to over twenty influenza cases per day. The first course of action associated with the specific hospital may indicate an instruction to order a small amount of an antiviral drug, oseltamivir, to treat influenza, and the second course of action can indicate an instruction to increase the amount of oseltamivir being ordered for the specific hospital, for example, due to the sharp increase in daily incidence of influenza. A notification can be sent to the pharmacy information system 36, nurse station 44, or other device 160 indicating an increased need for oseltamivir.
In certain aspects, the processor 212 of the monitoring system 40 is configured to receive a first identity of a caregiver at an institution and a proposed course of action for a medical entity, generate, based on a history of the caregiver within the institution, a modified course of action, and provide a notification of the modified course of action to the caregiver. For example, the history of the caregiver can indicate a level of waste of a medical item by the caregiver, and the modified course of action can include an indication of an action to decrease a level of waste of the medical item by the caregiver. The indicated action can be, for example, an instruction to reduce the number of the medical items being dispensed. As another example, the history of the caregiver can include an identification of one or many error made by the caregiver with a medical item or patient, and the modified course of action can include an indication of an action to decrease a likelihood of the error with the medical item, the patient, another medical item, or another patient. The indicated action can be, for instance, an instruction to not perform a certain action with a patient or medical item, or a suggestion for additional training.
The process 300 begins by proceeding from beginning step 301 when the caregiver enters parameters into the infusion pump 160 to administer a medication, to step 302 when a monitoring system 40 receives a first identifier identifying the medication and a second identifier identifying a first course of action, namely, certain parameters entered by the caregiver into the infusion pump 160 in order to administer the medication. Next, in step 303, a second course of action, namely, a requirement to confirm the medication parameters before administration, is generated based on a history of the medication and the entered parameters for administering the medication. Specifically, the history of the medication indicates that the caregiver has previously administered the medication incorrectly 20% of the time. Finally, as provided in the example illustration of
Computer system 500 (e.g., monitoring system 40, the device 160, and the server 130) includes a bus 508 or other communication mechanism for communicating information, and a processor 502 (e.g., processor 212, 154, and 136) coupled with bus 508 for processing information. By way of example, the computer system 500 may be implemented with one or more processors 502. Processor 502 may be a general-purpose microprocessor, a microcontroller, a Digital Signal Processor (DSP), an Application Specific Integrated Circuit (ASIC), a Field Programmable Gate Array (FPGA), a Programmable Logic Device (PLD), a controller, a state machine, gated logic, discrete hardware components, or any other suitable entity that can perform calculations or other manipulations of information.
Computer system 500 can include, in addition to hardware, code that creates an execution environment for the computer program in question, e.g., code that constitutes processor firmware, a protocol stack, a database management system, an operating system, or a combination of one or more of them stored in an included memory 504 (e.g., memory 42, 152, or 132), such as a Random Access Memory (RAM), a flash memory, a Read Only Memory (ROM), a Programmable Read-Only Memory (PROM), an Erasable PROM (EPROM), registers, a hard disk, a removable disk, a CD-ROM, a DVD, or any other suitable storage device, coupled to bus 508 for storing information and instructions to be executed by processor 502. The processor 502 and the memory 504 can be supplemented by, or incorporated in, special purpose logic circuitry.
The instructions may be stored in the memory 504 and implemented in one or more computer program products, i.e., one or more modules of computer program instructions encoded on a computer readable medium for execution by, or to control the operation of, the computer system 500, and according to any method well known to those of skill in the art, including, but not limited to, computer languages such as data-oriented languages (e.g., SQL, dBase), system languages (e.g., C, Objective-C, C++, Assembly), architectural languages (e.g., Java, .NET), and application languages (e.g., PHP, Ruby, Perl, Python). Instructions may also be implemented in computer languages such as array languages, aspect-oriented languages, assembly languages, authoring languages, command line interface languages, compiled languages, concurrent languages, curly-bracket languages, dataflow languages, data-structured languages, declarative languages, esoteric languages, extension languages, fourth-generation languages, functional languages, interactive mode languages, interpreted languages, iterative languages, list-based languages, little languages, logic-based languages, machine languages, macro languages, metaprogramming languages, multiparadigm languages, numerical analysis, non-English-based languages, object-oriented class-based languages, object-oriented prototype-based languages, off-side rule languages, procedural languages, reflective languages, rule-based languages, scripting languages, stack-based languages, synchronous languages, syntax handling languages, visual languages, wirth languages, embeddable languages, and xml-based languages. Memory 504 may also be used for storing temporary variable or other intermediate information during execution of instructions to be executed by processor 502.
A computer program as discussed herein does not necessarily correspond to a file in a file system. A program can be stored in a portion of a file that holds other programs or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files that store one or more modules, subprograms, or portions of code). A computer program can be deployed to be executed on one computer or on multiple computers that are located at one site or distributed across multiple sites and interconnected by a communication network. The processes and logic flows described in this specification can be performed by one or more programmable processors executing one or more computer programs to perform functions by operating on input data and generating output.
Computer system 500 further includes a data storage device 506 such as a magnetic disk or optical disk, coupled to bus 508 for storing information and instructions. Computer system 500 may be coupled via input/output module 510 to various devices. The input/output module 510 can be any input/output module. Example input/output modules 510 include data ports such as USB ports. The input/output module 510 is configured to connect to a communications module 512. Example communications modules 512 (e.g., communications module 210, 156, and 138) include networking interface cards, such as Ethernet cards and modems. In certain aspects, the input/output module 510 is configured to connect to a plurality of devices, such as an input device 514 (e.g., input device 216) and/or an output device 516 (e.g., display device 214). Example input devices 514 include a keyboard and a pointing device, e.g., a mouse or a trackball, by which a user can provide input to the computer system 500. Other kinds of input devices 514 can be used to provide for interaction with a user as well, such as a tactile input device, visual input device, audio input device, or brain-computer interface device. For example, feedback provided to the user can be any form of sensory feedback, e.g., visual feedback, auditory feedback, or tactile feedback; and input from the user can be received in any form, including acoustic, speech, tactile, or brain wave input. Example output devices 516 include display devices, such as a LED (light emitting diode), CRT (cathode ray tube), or LCD (liquid crystal display) screen, for displaying information to the user.
According to one aspect of the present disclosure, the monitoring system 40, the device 160, and the server 130 can be implemented using a computer system 500 in response to processor 502 executing one or more sequences of one or more instructions contained in memory 504. Such instructions may be read into memory 504 from another machine-readable medium, such as data storage device 506. Execution of the sequences of instructions contained in main memory 504 causes processor 502 to perform the process steps described herein. One or more processors in a multi-processing arrangement may also be employed to execute the sequences of instructions contained in memory 504. In alternative aspects, hard-wired circuitry may be used in place of or in combination with software instructions to implement various aspects of the present disclosure. Thus, aspects of the present disclosure are not limited to any specific combination of hardware circuitry and software.
Various aspects of the subject matter described in this specification can be implemented in a computing system that includes a back end component, e.g., as a data server, or that includes a middleware component, e.g., an application server, or that includes a front end component, e.g., a client computer having a graphical user interface or a Web browser through which a user can interact with an implementation of the subject matter described in this specification, or any combination of one or more such back end, middleware, or front end components. The components of the system can be interconnected by any form or medium of digital data communication, e.g., a communication network. The communication network (e.g., network 30) can include, for example, any one or more of a personal area network (PAN), a local area network (LAN), a campus area network (CAN), a metropolitan area network (MAN), a wide area network (WAN), a broadband network (BBN), the Internet, and the like. Further, the communication network can include, but is not limited to, for example, any one or more of the following network topologies, including a bus network, a star network, a ring network, a mesh network, a star-bus network, tree or hierarchical network, or the like. The communications modules can be, for example, modems or Ethernet cards.
Computing system 500 can include clients and servers. A client and server are generally remote from each other and typically interact through a communication network. The relationship of client and server arises by virtue of computer programs running on the respective computers and having a client-server relationship to each other. Computer system 500 can be, for example, and without limitation, a desktop computer, laptop computer, or tablet computer. Computer system 500 can also be embedded in another device, for example, and without limitation, a mobile telephone, a personal digital assistant (PDA), a mobile audio player, a Global Positioning System (GPS) receiver, a video game console, and/or a television set top box.
The term “machine-readable storage medium” or “computer readable medium” as used herein refers to any medium or media that participates in providing instructions or data to processor 502 for execution. Such a medium may take many forms, including, but not limited to, non-volatile media, volatile media, and transmission media. Non-volatile media include, for example, optical disks, magnetic disks, or flash memory, such as data storage device 506. Volatile media include dynamic memory, such as memory 504. Transmission media include coaxial cables, copper wire, and fiber optics, including the wires that comprise bus 508. Common forms of machine-readable media include, for example, floppy disk, a flexible disk, hard disk, magnetic tape, any other magnetic medium, a CD-ROM, DVD, any other optical medium, punch cards, paper tape, any other physical medium with patterns of holes, a RAM, a PROM, an EPROM, a FLASH EPROM, any other memory chip or cartridge, or any other medium from which a computer can read. The machine-readable storage medium can be a machine-readable storage device, a machine-readable storage substrate, a memory device, a composition of matter effecting a machine-readable propagated signal, or a combination of one or more of them.
As used herein, the phrase “at least one of” preceding a series of items, with the terms “and” or “or” to separate any of the items, modifies the list as a whole, rather than each member of the list (i.e., each item). The phrase “at least one of” does not require selection of at least one item; rather, the phrase allows a meaning that includes at least one of any one of the items, and/or at least one of any combination of the items, and/or at least one of each of the items. By way of example, the phrases “at least one of A, B, and C” or “at least one of A, B, or C” each refer to only A, only B, or only C; any combination of A, B, and C; and/or at least one of each of A, B, and C.
Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.
A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” The term “some” refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.
While this specification contains many specifics, these should not be construed as limitations on the scope of what may be claimed, but rather as descriptions of particular implementations of the subject matter. Certain features that are described in this specification in the context of separate embodiments can also be implemented in combination in a single embodiment. Conversely, various features that are described in the context of a single embodiment can also be implemented in multiple embodiments separately or in any suitable subcombination. Moreover, although features may be described above as acting in certain combinations and even initially claimed as such, one or more features from a claimed combination can in some cases be excised from the combination, and the claimed combination may be directed to a subcombination or variation of a subcombination.
Similarly, while operations are depicted in the drawings in a particular order, this should not be understood as requiring that such operations be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results. In certain circumstances, multitasking and parallel processing may be advantageous. Moreover, the separation of various system components in the aspects described above should not be understood as requiring such separation in all aspects, and it should be understood that the described program components and systems can generally be integrated together in a single software product or packaged into multiple software products.
The subject matter of this specification has been described in terms of particular aspects, but other aspects can be implemented and are within the scope of the following claims. For example, the actions recited in the claims can be performed in a different order and still achieve desirable results. As one example, the processes depicted in the accompanying figures do not necessarily require the particular order shown, or sequential order, to achieve desirable results. In certain implementations, multitasking and parallel processing may be advantageous. Other variations are within the scope of the following claims.
These and other implementations are within the scope of the following claims.
Number | Name | Date | Kind |
---|---|---|---|
2141006 | Marinsky | Dec 1938 | A |
3724455 | Unger | Apr 1973 | A |
3831006 | Chaffin, III et al. | Aug 1974 | A |
3848112 | Weichselbaum et al. | Nov 1974 | A |
3872448 | Mitchell, Jr. | Mar 1975 | A |
3898984 | Mandel et al. | Aug 1975 | A |
3910260 | Sarnoff et al. | Oct 1975 | A |
3921196 | Patterson | Nov 1975 | A |
3970996 | Yasaka et al. | Jul 1976 | A |
4051522 | Healy et al. | Sep 1977 | A |
4135241 | Stanis et al. | Jan 1979 | A |
4164320 | Irazoqui et al. | Aug 1979 | A |
4216462 | McGrath et al. | Aug 1980 | A |
4237344 | Moore | Dec 1980 | A |
4315309 | Coli | Feb 1982 | A |
4321461 | Walter, Jr. et al. | Mar 1982 | A |
4360125 | Martindale et al. | Nov 1982 | A |
4373527 | Fischell | Feb 1983 | A |
4476381 | Rubin | Oct 1984 | A |
4604847 | Moulding, Jr. et al. | Aug 1986 | A |
4636950 | Caswell et al. | Jan 1987 | A |
4674652 | Aten et al. | Jun 1987 | A |
4676776 | Howson | Jun 1987 | A |
4688026 | Scribner et al. | Aug 1987 | A |
4695954 | Rose et al. | Sep 1987 | A |
4696671 | Epstein et al. | Sep 1987 | A |
4731726 | Allen | Mar 1988 | A |
4733364 | Yamagata | Mar 1988 | A |
4756706 | Kerns et al. | Jul 1988 | A |
4778449 | Weber et al. | Oct 1988 | A |
4785969 | McLaughlin | Nov 1988 | A |
4803625 | Fu et al. | Feb 1989 | A |
4810243 | Howson | Mar 1989 | A |
4828545 | Epstein et al. | May 1989 | A |
4831562 | McIntosh et al. | May 1989 | A |
4835372 | Gombrich et al. | May 1989 | A |
4839806 | Goldfischer et al. | Jun 1989 | A |
4847764 | Halvorson | Jul 1989 | A |
4850009 | Zook et al. | Jul 1989 | A |
4853521 | Claeys et al. | Aug 1989 | A |
4855909 | Vincent et al. | Aug 1989 | A |
4857713 | Brown | Aug 1989 | A |
4857716 | Gombrich et al. | Aug 1989 | A |
4865584 | Epstein et al. | Sep 1989 | A |
4882575 | Kawahara | Nov 1989 | A |
4899839 | Dessertine et al. | Feb 1990 | A |
4916441 | Gombrich et al. | Apr 1990 | A |
4918604 | Baum | Apr 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4942544 | McIntosh et al. | Jul 1990 | A |
4950246 | Muller | Aug 1990 | A |
4967928 | Carter | Nov 1990 | A |
4970669 | McIntosh et al. | Nov 1990 | A |
4978335 | Arthur, III | Dec 1990 | A |
5001630 | Wiltfong | Mar 1991 | A |
5006699 | Felkener et al. | Apr 1991 | A |
5036462 | Kaufman et al. | Jul 1991 | A |
5036852 | Leishman | Aug 1991 | A |
5072383 | Brimm et al. | Dec 1991 | A |
5077666 | Brimm et al. | Dec 1991 | A |
5078683 | Sancoff et al. | Jan 1992 | A |
5088056 | McIntosh et al. | Feb 1992 | A |
5088981 | Howson et al. | Feb 1992 | A |
5100380 | Epstein et al. | Mar 1992 | A |
5126957 | Kaufman et al. | Jun 1992 | A |
5142484 | Kaufman et al. | Aug 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5153827 | Coutre et al. | Oct 1992 | A |
5164575 | Neeley et al. | Nov 1992 | A |
5166498 | Neeley | Nov 1992 | A |
5171977 | Morrison | Dec 1992 | A |
5181910 | Scanlon | Jan 1993 | A |
5207642 | Orkin et al. | May 1993 | A |
5235507 | Sackler et al. | Aug 1993 | A |
5256157 | Samiotes et al. | Oct 1993 | A |
5258906 | Kroll et al. | Nov 1993 | A |
5265010 | Evans-Paganelli et al. | Nov 1993 | A |
5267174 | Kaufman et al. | Nov 1993 | A |
5291399 | Chaco | Mar 1994 | A |
5292029 | Pearson | Mar 1994 | A |
5307263 | Brown | Apr 1994 | A |
5312334 | Hara et al. | May 1994 | A |
5314243 | McDonald et al. | May 1994 | A |
5315505 | Pratt et al. | May 1994 | A |
5317506 | Coutre et al. | May 1994 | A |
H1324 | Dalke et al. | Jun 1994 | H |
5331547 | Laszlo | Jul 1994 | A |
5356378 | Doan | Oct 1994 | A |
5367555 | Isoyama | Nov 1994 | A |
5368554 | Nazarian et al. | Nov 1994 | A |
5371692 | Draeger et al. | Dec 1994 | A |
5374813 | Shipp | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5378231 | Johnson et al. | Jan 1995 | A |
5382232 | Hague et al. | Jan 1995 | A |
5390238 | Kirk | Feb 1995 | A |
5401059 | Ferrario | Mar 1995 | A |
5404384 | Colburn et al. | Apr 1995 | A |
5408443 | Weinberger | Apr 1995 | A |
5412372 | Parkhurst et al. | May 1995 | A |
5412564 | Ecer | May 1995 | A |
5416695 | Stutman et al. | May 1995 | A |
5456691 | Snell | Oct 1995 | A |
5460605 | Tuttle et al. | Oct 1995 | A |
5465082 | Chaco | Nov 1995 | A |
5472614 | Rossi | Dec 1995 | A |
5502944 | Kraft et al. | Apr 1996 | A |
5515426 | Yacenda et al. | May 1996 | A |
5522798 | Johnson et al. | Jun 1996 | A |
5533079 | Colburn et al. | Jul 1996 | A |
5536084 | Curtis et al. | Jul 1996 | A |
5538006 | Heim et al. | Jul 1996 | A |
5542420 | Goldman et al. | Aug 1996 | A |
5544649 | David et al. | Aug 1996 | A |
5544661 | Davis et al. | Aug 1996 | A |
5547470 | Johnson et al. | Aug 1996 | A |
5561412 | Novak et al. | Oct 1996 | A |
5562232 | Pearson | Oct 1996 | A |
5564803 | McDonald et al. | Oct 1996 | A |
5573506 | Vasko | Nov 1996 | A |
5582593 | Hultman | Dec 1996 | A |
5583758 | McIlroy et al. | Dec 1996 | A |
5592374 | Fellegara et al. | Jan 1997 | A |
5594786 | Chaco | Jan 1997 | A |
5597995 | Williams et al. | Jan 1997 | A |
5601445 | Schipper et al. | Feb 1997 | A |
5622429 | Heinze | Apr 1997 | A |
5628309 | Brown | May 1997 | A |
5630710 | Tune et al. | May 1997 | A |
5633910 | Cohen | May 1997 | A |
5643212 | Coutre et al. | Jul 1997 | A |
5644778 | Burks et al. | Jul 1997 | A |
5645531 | Thompson et al. | Jul 1997 | A |
5651775 | Walker et al. | Jul 1997 | A |
5655118 | Heindel et al. | Aug 1997 | A |
5657236 | Conkright | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5672154 | Sillen et al. | Sep 1997 | A |
5681285 | Ford et al. | Oct 1997 | A |
5683367 | Jordan et al. | Nov 1997 | A |
5685844 | Marttila | Nov 1997 | A |
5689229 | Chaco et al. | Nov 1997 | A |
5692640 | Caulfield et al. | Dec 1997 | A |
5699038 | Ulrich et al. | Dec 1997 | A |
5700998 | Palti | Dec 1997 | A |
5703786 | Conkright | Dec 1997 | A |
5704352 | Tremblay et al. | Jan 1998 | A |
5710551 | Ridgeway | Jan 1998 | A |
5712913 | Chaum | Jan 1998 | A |
5713856 | Eggers | Feb 1998 | A |
5721913 | Ackroff et al. | Feb 1998 | A |
5733259 | Valcke et al. | Mar 1998 | A |
5737539 | Edelson | Apr 1998 | A |
5738102 | Lemelson | Apr 1998 | A |
5752235 | Kehr et al. | May 1998 | A |
5758095 | Albaum et al. | May 1998 | A |
5758096 | Barsky et al. | May 1998 | A |
5760704 | Barton et al. | Jun 1998 | A |
5764034 | Bowman et al. | Jun 1998 | A |
5772585 | Lavin et al. | Jun 1998 | A |
5774865 | Glynn | Jun 1998 | A |
5781442 | Engleson et al. | Jul 1998 | A |
5790409 | Fedor et al. | Aug 1998 | A |
5795327 | Wilson et al. | Aug 1998 | A |
5803906 | Pratt et al. | Sep 1998 | A |
5807321 | Stoker et al. | Sep 1998 | A |
5807336 | Russo et al. | Sep 1998 | A |
5819229 | Boppe | Oct 1998 | A |
5822418 | Yacenda et al. | Oct 1998 | A |
5822544 | Chaco et al. | Oct 1998 | A |
5832488 | Eberhardt | Nov 1998 | A |
5833599 | Schrier et al. | Nov 1998 | A |
5842173 | Strum et al. | Nov 1998 | A |
5842976 | Williamson | Dec 1998 | A |
5845253 | Rensimer et al. | Dec 1998 | A |
5845254 | Lockwood et al. | Dec 1998 | A |
5845255 | Mayaud | Dec 1998 | A |
5845264 | Nelhaus | Dec 1998 | A |
5848593 | McGrady et al. | Dec 1998 | A |
5850344 | Conkright | Dec 1998 | A |
5852408 | Christiansen et al. | Dec 1998 | A |
5855550 | Lai et al. | Jan 1999 | A |
5867821 | Ballantyne et al. | Feb 1999 | A |
5871465 | Vasko | Feb 1999 | A |
5883806 | Meador et al. | Mar 1999 | A |
5885245 | Lynch et al. | Mar 1999 | A |
5894273 | Meador et al. | Apr 1999 | A |
5895371 | Levitas et al. | Apr 1999 | A |
5899998 | McGauley et al. | May 1999 | A |
5903211 | Flego et al. | May 1999 | A |
5905653 | Higham et al. | May 1999 | A |
5907490 | Oliver | May 1999 | A |
5911132 | Sloane | Jun 1999 | A |
5911687 | Sato et al. | Jun 1999 | A |
5912818 | McGrady | Jun 1999 | A |
5920054 | Uber, III | Jul 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5928329 | Clark et al. | Jul 1999 | A |
5930145 | Yuyama et al. | Jul 1999 | A |
5935099 | Peterson et al. | Aug 1999 | A |
5941710 | Lampotang et al. | Aug 1999 | A |
5942986 | Shabot et al. | Aug 1999 | A |
5950630 | Portwood et al. | Sep 1999 | A |
5950632 | Reber et al. | Sep 1999 | A |
5953099 | Walach | Sep 1999 | A |
5954641 | Kehr et al. | Sep 1999 | A |
5957885 | Bollish et al. | Sep 1999 | A |
5961036 | Michael et al. | Oct 1999 | A |
5961446 | Beller et al. | Oct 1999 | A |
5971593 | McGrady | Oct 1999 | A |
5995077 | Wilcox et al. | Nov 1999 | A |
6000828 | Leet | Dec 1999 | A |
6003006 | Colella | Dec 1999 | A |
6009333 | Chaco | Dec 1999 | A |
6021392 | Lester et al. | Feb 2000 | A |
6024699 | Surwit et al. | Feb 2000 | A |
6032155 | de la Huerga | Feb 2000 | A |
6039251 | Holowko et al. | Mar 2000 | A |
6047203 | Sackner et al. | Apr 2000 | A |
6048087 | Laurent et al. | Apr 2000 | A |
6053887 | Levitas et al. | Apr 2000 | A |
6063026 | Schauss et al. | May 2000 | A |
6082776 | Feinberg | Jul 2000 | A |
6112182 | Akers et al. | Aug 2000 | A |
RE36871 | Epstein et al. | Sep 2000 | E |
6134582 | Kennedy | Oct 2000 | A |
6135949 | Russo et al. | Oct 2000 | A |
6202923 | Boyer et al. | Mar 2001 | B1 |
6228057 | Vasko | May 2001 | B1 |
6241704 | Peterson et al. | Jun 2001 | B1 |
6269340 | Ford et al. | Jul 2001 | B1 |
6282441 | Raymond et al. | Aug 2001 | B1 |
6290681 | Brown | Sep 2001 | B1 |
6292698 | Duffin et al. | Sep 2001 | B1 |
6302844 | Walker et al. | Oct 2001 | B1 |
6312378 | Bardy | Nov 2001 | B1 |
6314556 | DeBusk et al. | Nov 2001 | B1 |
6319200 | Lai et al. | Nov 2001 | B1 |
6322502 | Schoenberg et al. | Nov 2001 | B1 |
6338007 | Broadfield et al. | Jan 2002 | B1 |
6339732 | Phoon et al. | Jan 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6409684 | Wilk | Jun 2002 | B1 |
6421650 | Goetz et al. | Jul 2002 | B1 |
6493747 | Simmon et al. | Dec 2002 | B2 |
6519569 | White et al. | Feb 2003 | B1 |
6529892 | Lambert | Mar 2003 | B1 |
6540672 | Simonsen et al. | Apr 2003 | B1 |
6558352 | Hogan | May 2003 | B1 |
6581606 | Kutzko et al. | Jun 2003 | B2 |
6671563 | Engelson et al. | Dec 2003 | B1 |
6745764 | Hickle | Jun 2004 | B2 |
6757898 | Ilsen et al. | Jun 2004 | B1 |
6785589 | Eggenberger et al. | Aug 2004 | B2 |
6796956 | Hartlaub et al. | Sep 2004 | B2 |
6799149 | Hartlaub | Sep 2004 | B2 |
6847861 | Lunak et al. | Jan 2005 | B2 |
6856247 | Wallace | Feb 2005 | B1 |
6993402 | Klass et al. | Jan 2006 | B2 |
7034691 | Rapaport et al. | Apr 2006 | B1 |
7054844 | Fletcher et al. | May 2006 | B2 |
7096072 | Engleson et al. | Aug 2006 | B2 |
7215991 | Besson et al. | May 2007 | B2 |
7229430 | Hickle et al. | Jun 2007 | B2 |
7230529 | Ketcherside, Jr. et al. | Jun 2007 | B2 |
7256708 | Rosenfeld et al. | Aug 2007 | B2 |
7263492 | Suresh et al. | Aug 2007 | B1 |
7379885 | Zakim | May 2008 | B1 |
7384420 | Dycus et al. | Jun 2008 | B2 |
7398183 | Holland et al. | Jul 2008 | B2 |
7421709 | Watson et al. | Sep 2008 | B2 |
7433853 | Brockway et al. | Oct 2008 | B2 |
7471994 | Ford et al. | Dec 2008 | B2 |
7526769 | Watts et al. | Apr 2009 | B2 |
7587415 | Gaurav et al. | Sep 2009 | B2 |
7612679 | Fackler et al. | Nov 2009 | B1 |
7693697 | Westenskow et al. | Apr 2010 | B2 |
7769601 | Bleser et al. | Aug 2010 | B1 |
7771385 | Eggers et al. | Aug 2010 | B2 |
7771386 | Eggers et al. | Aug 2010 | B2 |
7787946 | Stahmann et al. | Aug 2010 | B2 |
7796045 | Spear et al. | Sep 2010 | B2 |
7835927 | Schlotterbeck et al. | Nov 2010 | B2 |
7847970 | McGrady | Dec 2010 | B1 |
7860583 | Condurso et al. | Dec 2010 | B2 |
7962544 | Torok et al. | Jun 2011 | B2 |
7970550 | Arakelyan et al. | Jun 2011 | B2 |
8005688 | Coffman et al. | Aug 2011 | B2 |
8024200 | Jennings et al. | Sep 2011 | B2 |
8160895 | Schmitt et al. | Apr 2012 | B2 |
8197437 | Kalafut et al. | Jun 2012 | B2 |
8291337 | Gannin et al. | Oct 2012 | B2 |
8340792 | Condurso et al. | Dec 2012 | B2 |
8689008 | Rangadass et al. | Apr 2014 | B2 |
20010037083 | Hartlaub et al. | Nov 2001 | A1 |
20010044731 | Coffman et al. | Nov 2001 | A1 |
20020010679 | Felsher | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020016923 | Knaus et al. | Feb 2002 | A1 |
20020022973 | Sun et al. | Feb 2002 | A1 |
20020026223 | Riff et al. | Feb 2002 | A1 |
20020033548 | Brodkin et al. | Mar 2002 | A1 |
20020035484 | McCormick | Mar 2002 | A1 |
20020038392 | De La Huerga | Mar 2002 | A1 |
20020042636 | Koshiol et al. | Apr 2002 | A1 |
20020046346 | Evans | Apr 2002 | A1 |
20020077849 | Baruch et al. | Jun 2002 | A1 |
20020087114 | Hartlaub | Jul 2002 | A1 |
20020116509 | De La Huerga | Aug 2002 | A1 |
20020120350 | Klass et al. | Aug 2002 | A1 |
20020169636 | Eggers et al. | Nov 2002 | A1 |
20020198624 | Greenwald et al. | Dec 2002 | A1 |
20030009244 | Engleson et al. | Jan 2003 | A1 |
20030036683 | Kehr et al. | Feb 2003 | A1 |
20030045858 | Struys et al. | Mar 2003 | A1 |
20030051737 | Hickle et al. | Mar 2003 | A1 |
20030063524 | Niemiec et al. | Apr 2003 | A1 |
20030069481 | Hervy et al. | Apr 2003 | A1 |
20030105389 | Noonan et al. | Jun 2003 | A1 |
20030105555 | Lunak et al. | Jun 2003 | A1 |
20030106553 | Vanderveen | Jun 2003 | A1 |
20030114836 | Estes et al. | Jun 2003 | A1 |
20030121517 | McFarland | Jul 2003 | A1 |
20030129578 | Mault | Jul 2003 | A1 |
20030135087 | Hickle et al. | Jul 2003 | A1 |
20030135388 | Martucci et al. | Jul 2003 | A1 |
20030139701 | White et al. | Jul 2003 | A1 |
20030140928 | Bui et al. | Jul 2003 | A1 |
20030140929 | Wilkes et al. | Jul 2003 | A1 |
20030149599 | Goodall et al. | Aug 2003 | A1 |
20030156143 | Westenskow et al. | Aug 2003 | A1 |
20030158746 | Forrester | Aug 2003 | A1 |
20030163223 | Blomquist | Aug 2003 | A1 |
20030205897 | Kaufman | Nov 2003 | A1 |
20030236683 | Henderson et al. | Dec 2003 | A1 |
20040068229 | Jansen et al. | Apr 2004 | A1 |
20040073329 | Engleson et al. | Apr 2004 | A1 |
20040107118 | Harnsberger et al. | Jun 2004 | A1 |
20040122702 | Sabol et al. | Jun 2004 | A1 |
20040122705 | Sabol et al. | Jun 2004 | A1 |
20040122719 | Sabol et al. | Jun 2004 | A1 |
20040122790 | Walker et al. | Jun 2004 | A1 |
20040128162 | Schlotterbeck et al. | Jul 2004 | A1 |
20040152622 | Keith et al. | Aug 2004 | A1 |
20040167465 | Mihai et al. | Aug 2004 | A1 |
20040167804 | Simpson et al. | Aug 2004 | A1 |
20040172283 | Vanderveen et al. | Sep 2004 | A1 |
20040172300 | Mihai | Sep 2004 | A1 |
20040172302 | Martucci et al. | Sep 2004 | A1 |
20040176297 | Cheung et al. | Sep 2004 | A1 |
20040188998 | Henthorn | Sep 2004 | A1 |
20040193325 | Bonderud et al. | Sep 2004 | A1 |
20040193446 | Mayer et al. | Sep 2004 | A1 |
20040260478 | Schwamm | Dec 2004 | A1 |
20050010166 | Hickle | Jan 2005 | A1 |
20050020996 | Hartlaub et al. | Jan 2005 | A1 |
20050021297 | Hartlaub | Jan 2005 | A1 |
20050033606 | Miller | Feb 2005 | A1 |
20050049179 | Davidson et al. | Mar 2005 | A1 |
20050055242 | Bello et al. | Mar 2005 | A1 |
20050088296 | Lee | Apr 2005 | A1 |
20050096941 | Tong | May 2005 | A1 |
20050097566 | Watts et al. | May 2005 | A1 |
20050107914 | Engleson et al. | May 2005 | A1 |
20050108057 | Cohen et al. | May 2005 | A1 |
20050113945 | Engleson et al. | May 2005 | A1 |
20050119788 | Engleson et al. | Jun 2005 | A1 |
20050144043 | Holland et al. | Jun 2005 | A1 |
20050145010 | Vanderveen et al. | Jul 2005 | A1 |
20050148890 | Hastings | Jul 2005 | A1 |
20050171815 | Vanderveen | Aug 2005 | A1 |
20050224083 | Crass et al. | Oct 2005 | A1 |
20050278194 | Holland et al. | Dec 2005 | A1 |
20060026205 | Butterfield | Feb 2006 | A1 |
20060047538 | Condurso et al. | Mar 2006 | A1 |
20060053036 | Coffman et al. | Mar 2006 | A1 |
20060101072 | Busche et al. | May 2006 | A1 |
20060122481 | Sievenpiper et al. | Jun 2006 | A1 |
20060190302 | Eggers et al. | Aug 2006 | A1 |
20060200369 | Batch et al. | Sep 2006 | A1 |
20060206356 | Vanderveen | Sep 2006 | A1 |
20060217628 | Huiku | Sep 2006 | A1 |
20060218015 | Walker et al. | Sep 2006 | A1 |
20060229551 | Martinez et al. | Oct 2006 | A1 |
20060249423 | Reijonen | Nov 2006 | A1 |
20060271401 | Lassetter et al. | Nov 2006 | A1 |
20060287890 | Stead et al. | Dec 2006 | A1 |
20070015972 | Wang et al. | Jan 2007 | A1 |
20070043767 | Osborne et al. | Feb 2007 | A1 |
20070061266 | Moore et al. | Mar 2007 | A1 |
20070061393 | Moore | Mar 2007 | A1 |
20070083389 | Dyer et al. | Apr 2007 | A1 |
20070106457 | Rosenberg | May 2007 | A1 |
20070106753 | Moore | May 2007 | A1 |
20070106754 | Moore | May 2007 | A1 |
20070156860 | Nedelcu et al. | Jul 2007 | A1 |
20070168301 | Eisner et al. | Jul 2007 | A1 |
20070208454 | Forrester et al. | Sep 2007 | A1 |
20070210157 | Miller | Sep 2007 | A1 |
20070286466 | Heffernan et al. | Dec 2007 | A1 |
20070293843 | Ireland et al. | Dec 2007 | A1 |
20080015549 | Maughan | Jan 2008 | A1 |
20080025230 | Patel et al. | Jan 2008 | A1 |
20080034323 | Blomquist | Feb 2008 | A1 |
20080040151 | Moore | Feb 2008 | A1 |
20080046292 | Myers et al. | Feb 2008 | A1 |
20080141272 | Borgendale et al. | Jun 2008 | A1 |
20080162254 | Herger et al. | Jul 2008 | A1 |
20080164998 | Scherpbier et al. | Jul 2008 | A1 |
20080169045 | Tribble et al. | Jul 2008 | A1 |
20080195246 | Tribble et al. | Aug 2008 | A1 |
20080272138 | Ross et al. | Nov 2008 | A1 |
20080317672 | Viertio-Oja | Dec 2008 | A1 |
20090012812 | Rausch et al. | Jan 2009 | A1 |
20090012813 | Berzansky | Jan 2009 | A1 |
20090099867 | Newman | Apr 2009 | A1 |
20090112333 | Sahai | Apr 2009 | A1 |
20090150484 | Roberts | Jun 2009 | A1 |
20090210252 | Silver | Aug 2009 | A1 |
20090240651 | Fletcher et al. | Sep 2009 | A1 |
20090306585 | Pang et al. | Dec 2009 | A1 |
20090306944 | Willmann et al. | Dec 2009 | A1 |
20090319623 | Srinivasan et al. | Dec 2009 | A1 |
20100037067 | Rangadass et al. | Feb 2010 | A1 |
20100094653 | Tribble et al. | Apr 2010 | A1 |
20100121654 | Portnoy et al. | May 2010 | A1 |
20100161113 | Tribble et al. | Jun 2010 | A1 |
20100169120 | Herbst et al. | Jul 2010 | A1 |
20100169771 | Pelegrin et al. | Jul 2010 | A1 |
20100174552 | Hawkes et al. | Jul 2010 | A1 |
20100174553 | Kaufman et al. | Jul 2010 | A1 |
20100179825 | Hanov et al. | Jul 2010 | A1 |
20100241453 | Malec | Sep 2010 | A1 |
20100241456 | Miller et al. | Sep 2010 | A1 |
20100271218 | Hoag et al. | Oct 2010 | A1 |
20100280840 | Fukushi et al. | Nov 2010 | A1 |
20100323397 | Reavy et al. | Dec 2010 | A1 |
20110015941 | Backhaus | Jan 2011 | A1 |
20110046975 | Hoffman | Feb 2011 | A1 |
20110060758 | Schlotterbeck et al. | Mar 2011 | A1 |
20110119612 | Gannon et al. | May 2011 | A1 |
20110179405 | Dicks et al. | Jul 2011 | A1 |
20110202495 | Gawlick | Aug 2011 | A1 |
20110282691 | Coffman et al. | Nov 2011 | A1 |
20110288882 | Halow | Nov 2011 | A1 |
20110313787 | Rangadass et al. | Dec 2011 | A1 |
20120011253 | Friedman et al. | Jan 2012 | A1 |
20120016215 | Condurso et al. | Jan 2012 | A1 |
20120041775 | Cosentino et al. | Feb 2012 | A1 |
20120053533 | Butterfield et al. | Mar 2012 | A1 |
20120075061 | Barnes | Mar 2012 | A1 |
20120136673 | Presley et al. | May 2012 | A1 |
20120173264 | Brush et al. | Jul 2012 | A1 |
20120182939 | Rajan et al. | Jul 2012 | A1 |
20120185267 | Kamen et al. | Jul 2012 | A1 |
20120191052 | Rao | Jul 2012 | A1 |
20120239824 | Nguyen et al. | Sep 2012 | A1 |
20120247480 | Varga | Oct 2012 | A1 |
20120253835 | Tracy et al. | Oct 2012 | A1 |
20120265549 | Virolainen | Oct 2012 | A1 |
20130018356 | Prince et al. | Jan 2013 | A1 |
20130085771 | Ghanbari et al. | Apr 2013 | A1 |
20130096444 | Condurso et al. | Apr 2013 | A1 |
20130197927 | Vanderveen et al. | Aug 2013 | A1 |
20130197928 | Vanderveen et al. | Aug 2013 | A1 |
20130197929 | Vanderveen et al. | Aug 2013 | A1 |
20130197930 | Garibaldi et al. | Aug 2013 | A1 |
20130197931 | Gupta et al. | Aug 2013 | A1 |
20130204433 | Gupta et al. | Aug 2013 | A1 |
20130204637 | Vanderveen et al. | Aug 2013 | A1 |
20130262138 | Jaskela et al. | Oct 2013 | A1 |
20140028464 | Garibaldi | Jan 2014 | A1 |
20140100868 | Condurso et al. | Apr 2014 | A1 |
20140278466 | Simmons et al. | Sep 2014 | A1 |
20140297313 | Condurso et al. | Oct 2014 | A1 |
20140350950 | Jaskela et al. | Nov 2014 | A1 |
20150250948 | Gupta et al. | Sep 2015 | A1 |
20160000997 | Batch et al. | Jan 2016 | A1 |
Number | Date | Country |
---|---|---|
2472098 | Jul 2003 | CA |
2554903 | Apr 2005 | CA |
1759398 | Apr 2006 | CN |
101116077 | Jan 2008 | CN |
101146055 | Mar 2008 | CN |
201110955 | Sep 2008 | CN |
101890193 | Nov 2010 | CN |
102068725 | May 2011 | CN |
102688532 | Sep 2012 | CN |
4023785 | Jan 1992 | DE |
0192786 | Sep 1986 | EP |
0384155 | Aug 1990 | EP |
0595474 | May 1994 | EP |
0649316 | Apr 1995 | EP |
0652528 | May 1995 | EP |
0784283 | Jul 1997 | EP |
0921488 | Jun 1999 | EP |
1003121 | May 2000 | EP |
1018347 | Jul 2000 | EP |
1237113 | Sep 2002 | EP |
2141006 | Dec 1984 | GB |
62114562 | May 1987 | JP |
5168708 | Jul 1993 | JP |
11-505352 | May 1999 | JP |
2002-520718 | Jul 2002 | JP |
2003085283 | Mar 2003 | JP |
2004287616 | Oct 2004 | JP |
2006155070 | Jun 2006 | JP |
1020070045611 | May 2007 | KR |
1020080013129 | Feb 2008 | KR |
100847397 | Jul 2008 | KR |
1020100125972 | Dec 2010 | KR |
1020110070824 | Jun 2011 | KR |
1020120076615 | Jul 2012 | KR |
1020120076635 | Jul 2012 | KR |
522631 | Jul 2004 | NZ |
WO9322735 | Nov 1993 | WO |
WO9405344 | Mar 1994 | WO |
WO9408647 | Apr 1994 | WO |
WO9413250 | Jun 1994 | WO |
WO9523378 | Aug 1995 | WO |
WO9620745 | Jul 1996 | WO |
WO-9620745 | Jul 1996 | WO |
WO9625214 | Aug 1996 | WO |
WO-9625214 | Aug 1996 | WO |
WO9636923 | Nov 1996 | WO |
WO9704712 | Feb 1997 | WO |
WO9813783 | Apr 1998 | WO |
WO9828676 | Jul 1998 | WO |
WO9909505 | Feb 1999 | WO |
WO9910829 | Mar 1999 | WO |
WO9910830 | Mar 1999 | WO |
WO9935588 | Jul 1999 | WO |
WO9944167 | Sep 1999 | WO |
WO9945490 | Sep 1999 | WO |
WO9946718 | Sep 1999 | WO |
WO9967732 | Dec 1999 | WO |
WO0003344 | Jan 2000 | WO |
WO0004521 | Jan 2000 | WO |
WO0018449 | Apr 2000 | WO |
WO0032088 | Jun 2000 | WO |
WO0032098 | Jun 2000 | WO |
WO0186506 | Nov 2001 | WO |
WO0188828 | Nov 2001 | WO |
WO0236044 | May 2002 | WO |
WO02069099 | Sep 2002 | WO |
WO03038566 | May 2003 | WO |
WO03053503 | Jul 2003 | WO |
WO03092769 | Nov 2003 | WO |
WO03094091 | Nov 2003 | WO |
WO2004060443 | Jul 2004 | WO |
WO2004061745 | Jul 2004 | WO |
WO-2010124016 | Oct 2010 | WO |
WO-2010124328 | Nov 2010 | WO |
WO-2012095829 | Jul 2012 | WO |
Entry |
---|
“‘Smart’ Infusion Pumps Join CPOE and Bar Coding as Important Ways to Prevent Medication Errors,” ISMP—Medication Safety Alert, Feb. 7, 2002, 2 pgs., Institute for Safe Medication Practices. |
“General-Purpose Infusion Pumps,” Evaluation—Health Devices, Oct. 2002, pp. 353-387, vol. 31(10), ECRI Institute. |
“Infusion Pump Technology,” Health Devices, Apr.-May 1998, pp. 150-170, vol. 27(4-5), ECRI Institute. |
“Infusion Pumps, General-Purpose,” Healthcare Product Comparison System, 2007, pp. 1-54, ECRI Institute. |
“Infusion Pumps, Large-Volume,” Healthcare Product Comparison System, 2010, pp. 1-51, ECRI Institute. |
Anonymous, Guardrails® Safety Software—Medley TM Medication Safety System, Alaris Medical Systems XP-00234431; 2002 Alaris Medical Systems Inc. Nov. 2002, SSM @2159C. |
Baldauf-Sobez et al., “How Siemens' Computerized Physician Order Entry Helps Prevent the Human Error,” Electromedica, vol. 71, No. 1, 2003, pp. 2-10. |
Calabrese, et al., “Medication administration errors in adult patients in the ICU,” Intensive Care Med, 2001, pp. 1592-1598, vol. 27, Springer-Verlag. |
Eskew, James et al., Using Innovative Technologies to Set New Safety Standards for the Infusion of Intravenous Medications, Hospital Pharmacy, vol. 37, No. 11, pp. 1179-1189, 2002, Facts and Comparisons. |
Kohn, et al., “To Err is Human—Building a Safer Health System,” National Academy Press, 2002, pp. i-287, National Academy of Sciences. |
Lesar, “Recommendations for Reducing Medication Errors,” Medscape Pharmacists, posted Jul. 24, 2000, 10 pgs, vol. 1(2), Medscape Pharmacists, <http://www.medscape.com>. |
Meier, “Hospital Products Get Seal of Approval at a Price,” The New York Times, Apr. 23, 2002, 5 pgs. |
Shabot, et al., “Wireless clinical alerts for critical medication, laboratory and physiologic data,” System Sciences 2000. Proceedings of the 33rd Annual Conference on Jan. 4-7, 2000, Piscataway, NJ, IEEE, Jan. 4, 2000. |
Williams, et al., “Reducing the Risk of User Error with Infusion Pumps,” Professional Nurse—Safe Practice—Infusion Devices, Mar. 2000, pp. 382-384, vol. 15(6). |
Yokoi, “Prevention of Errors in Injection/Drip Infusion—No excuse for ignorance!—Essential Points of Accident Prevention, IV Infusion Pump, Syringe-pump Accident Prevention,” JIN Special, Igaku Shoin K.K., Dec. 1, 2001, pp. 109-120, No. 70. |
U.S. Appl. No. 13/901,501, filed May 23, 2013. |
International Search Report and Written Opinion of the International Searching Authority dated Sep. 5, 2014, for PCT application PCT/US2014/037577. |
International Search Reports and Written Opinion of the International Searching Authority dated Jun. 18, 2014 and Jun. 19, 2014 for PCT applications PCT/US2014/022830, PCT/US2014/022835 and PCT/US2014/022837. Office Action issued in U.S. Appl. No. 13/802,433 dated Aug. 25, 2014. |
Non-Final Office Action dated Oct. 14, 2014, issued in U.S. Appl. No. 11/326,145, and Non-Final Office Action dated Oct. 24, 2014, issued in U.S. Appl. No. 13/559,537. |
International Search Reports and Written Opinions of the International Searching Authority dated Jun. 19, 2014 and Jun. 24, 2014 for PCT Application Nos. PCT/US2014/022840 and PCT/US2014/022532. |
U.S. Appl. No. 90/009,912, filed Aug. 12, 2013, Schlotterbeck et al. |
U.S. Appl. No. 90/011,697, filed Aug. 12, 2013, Schlotterbeck et al. |
Queensland Health. Use of returned or unused dispensed medicines, Jan. 5, 2005, Queensland Government. pp. 1-2. |
International Search Report and Written Opinion, Application No. PCT/US2014/022840, Jun. 19, 2014, 13 pgs. |
International Search Report and Written Opinion, Application No. PCT/US2014/022832, Jun. 24, 2014, 12 pgs. |
Extended European Search Report for Application No. 14779655.1, dated Jul. 14, 2016, 8 pages. |
Extended European Search Report for Application No. 14780320.9, dated Jul. 1, 2016, 7 pages. |
Evans, R. S. et al., “Enhanced notification of infusion pump programming errors”, Studies in health technology and informatics, Jan. 1, 2010, pp. 734-738, XP055305644, Netherlands DOI: 10.3233/978-1-60750-588-4-734 Retrieved from the Internet: URL:http://booksonline.iospress.nl/Extern/EnterMedLine.aspx?ISSN=0926-9630&Volume=160&SPage=734 [retrieved on Sep. 26, 2016]. |
Extended European Search Report and Written Opinion for Application No. 14772937.0, dated Oct. 10, 2016, 9 pages. |
Extended European Search Report and Written Opinion for Application No. 14779139.6, dated Nov. 7, 2016, 7 pages. |
Extended European Search Report for Application No. 14801713.0, dated Jan. 16, 2017, 8 pages. |
Canadian Office Action for Application No. 2512991, dated Mar. 2, 2017, 4 pages. |
Extended European Search Report for Application No. 14801726.2, dated Jan. 5, 2017, 8 pages. |
Extended European Search Report for Application No. 14775918.7, dated Sep. 13, 2016, 10 pages. |
Chinese Office Action for Application No. 201480015147.6, dated Mar. 10, 2017, 10 pages excluding translation. |
Canadian Office Action for Application No. 2551903, dated Mar. 28, 2017, 7 pages. |
European Office Action for Application No. 12756903.6, dated Apr. 19, 2017, 5 pages. |
Office Action for United Arab Emirates Application No. UAE/P/0962/2013, dated Apr. 17, 2017, 18 pages. |
Number | Date | Country | |
---|---|---|---|
20130197931 A1 | Aug 2013 | US |